FDA Clearance Tracker · P190015-S026
TREO® Abdominal Stent-Graft System
Last checked: Nov 20, 2026Latest source record: Mar 26, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Mar 26, 2026
Approved
Time to decision
177 days
Received Sep 30, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P190015-S026
- Device name
- TREO® Abdominal Stent-Graft System
- Applicant
- Bolton Medical, Inc.
- Applicant location
- Sunrise, FL
- Received
- Sep 30, 2025
- Decided
- Mar 26, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P190015
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
approval for the addition of 140mm contralateral length TREO Main Bifurcated Stent Graft size and modifications to the TREO B2/C2 delivery system
Source documents
Other decisions for Bolton Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- RelayPro Thoracic Stent-Graft SystemPMA supplement
P200045-S002 · Decided Mar 7, 2023 · 295 days after receipt · Panel Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
P200045 · Decided Aug 5, 2021 · 258 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
P190015 · Decided May 4, 2020 · 336 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.